Concepedia

Marice Alcantara

MA

9

Publications

704

Citations

9

H-Index

2014

Active since

Affiliations

City of Hope(Current)

Beckman Research Institute

Yale University

Translational Genomics Research Institute

The University of Texas MD Anderson Cancer Center

Marice Alcantara is an author at City of Hope specializing in cancer therapeutics, medicine, and antimicrobial stewardship.

ORCID

Top concepts

Publications per year

2014–2024

9

Publications

9

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot et al. · Nature Medicine · 2022 · 427 citations · Full text

Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity

Dayson Moreira, Sagus Sampath, Haejung Won et al. · Journal of Clinical Investigation · 2020 · 79 citations · Full text

Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Hedyeh Ebrahimi, Nazlı Dizman, Luís Meza et al. · Nature Medicine · 2024 · 64 citations · Full text

Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma

Alex Chehrazi‐Raffle, Luís Meza, Marice Alcantara et al. · Journal for ImmunoTherapy of Cancer · 2021 · 37 citations · Full text

Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3

Jeremy Hall, Zhuoran Zhang, S. Bhattacharya et al. · Molecular Therapy — Nucleic Acids · 2024 · 29 citations · Full text

Rows per page

1–5 of 9